The scientific programme for FIGO Montréal 2027 is guided by the Congress theme: Advancing innovation, equity and excellence in women’s health.
Through a multidisciplinary programme spanning the full spectrum of obstetrics and gynaecology, the Congress will explore the latest evidence, emerging technologies and collaborative approaches that are advancing women’s health worldwide.
Together, the programme reflects FIGO’s commitment to advancing knowledge, fostering collaboration and improving health outcomes through evidence-based practice and innovation.
Leader: Professor Liona Poon, Hong Kong
1.1 Prenatal diagnosis, genetics, therapy and surgery
1.2 Nutrition in pregnancy and breastfeeding
1.3 Ultrasound in pregnancy
1.4 Infections, vaccination and anaemia in pregnancy
1.5 Preeclampsia and hypertensive disorders of pregnancy, including long-term health
Leader: Professor Fionnuala McAuliffe, Ireland
2.1 Obstetric emergencies, including post-partum haemorrhage (PPH) and sepsis
2.2 Operative obstetrics, including c-section, operative vaginal delivery and perineal trauma
2.3 Antenatal, postnatal and neonatal care
2.4 Midwifery care
2.5 Preterm birth and stillbirth
2.6 Maternal mortality
Leader: Dr Megan Wasson, USA
3.1 Urogynaecology, including pelvic organ prolapse and incontinence
3.2 Chronic pelvic pain
3.3 Fibroids, endometriosis and adenomyosis
3.4 Minimal access surgery, laparoscopy, robotics and hysteroscopy
3.5 Fistula prevention and treatment
3.6 Breast disease
3.7 Gender-affirming care
Leader: Dr Aparna Sridhar, USA
4.1 Contraception and family planning
4.2 Abortion care
4.3 Adolescent health
4.4 Sexual health and STI/HIV prevention
4.5 Women facing crisis
4.6 Female genital mutilation
Leader: Professor Anis Feki, Tunisia / Switzerland
5.1 Fertility
5.2 Innovation in reproductive technology
5.3 Environmental challenges
5.4 Legal and ethical aspects of human reproduction
5.5 Endometriosis and adenomyosis
Leader: Professor Etsuko Miyagi, Japan
6.1 Cervical cancer and HPV
6.2 Vaginal and vulvar cancers
6.3 Ovarian and uterine cancers
6.4 Breast cancer
6.5 Genetics, screening and prevention
6.6 Diagnosis and management of gynaecological malignancies
Leader: Professor Basil Tarlatzis, Greece
7.1 Menstrual health
7.2 Menopause and perimenopause
7.3 Diabetes
7.4 PCOS/PMOS
7.5 Nutrition
7.6 Obesity
1.1 Prenatal diagnosis, genetics, therapy and surgery
1.2 Nutrition in pregnancy and breastfeeding
1.3 Ultrasound in pregnancy
1.4 Infections, vaccination and anaemia in pregnancy
1.5 Preeclampsia and hypertensive disorders of pregnancy, including long-term health
2.1 Obstetric emergencies, including post-partum haemorrhage (PPH) and sepsis
2.2 Operative obstetrics, including c-section, operative vaginal delivery and perineal trauma
2.3 Antenatal, postnatal and neonatal care
2.4 Midwifery care
2.5 Preterm birth and stillbirth
2.6 Maternal mortality
3.1 Urogynaecology, including pelvic organ prolapse and incontinence
3.2 Chronic pelvic pain
3.3 Fibroids, endometriosis and adenomyosis
3.4 Minimal access surgery, laparoscopy, robotics and hysteroscopy
3.5 Fistula prevention and treatment
3.6 Breast disease
3.7 Gender-affirming care
4.1 Contraception and family planning
4.2 Abortion care
4.3 Adolescent health
4.4 Sexual health and STI/HIV prevention
4.5 Women facing crisis
4.6 Female genital mutilation
5.1 Fertility
5.2 Innovation in reproductive technology
5.3 Environmental challenges
5.4 Legal and ethical aspects of human reproduction
5.5 Endometriosis and adenomyosis
6.1 Cervical cancer and HPV
6.2 Vaginal and vulvar cancers
6.3 Ovarian and uterine cancers
6.4 Breast cancer
6.5 Genetics, screening and prevention
6.6 Diagnosis and management of gynaecological malignancies
7.1 Menstrual health
7.2 Menopause and perimenopause
7.3 Diabetes
7.4 PCOS/PMOS
7.5 Nutrition
7.6 Obesity
| Stream name | Stream topics |
|---|---|
|
Maternal fetal medicine
Leader: Professor Liona Poon, Hong Kong
|
|
|
Clinical obstetrics
Leader: Professor Fionnuala McAuliffe, Ireland
|
|
|
Gynaecology
Leader: Dr Megan Wasson, USA
|
|
|
Sexual and reproductive health and rights
Leader: Dr Aparna Sridhar, USA
|
|
|
Reproductive medicine
Leader: Professor Anis Feki, Tunisia / Switzerland
|
|
|
Women’s cancer
Leader: Professor Etsuko Miyagi, Japan
|
|
|
Endocrinology
Leader: Professor Basil Tarlatzis, Greece
|
|
|
Pain
Leader: Dr Juan Diego Villegas-Echeverri, Colombia
|
Anaemia
Leader: Dr Hema Divakar, India
|
Obesity
Leader: Professor Cynthia Maxwell, Canada
|
|
Advocacy and health systems strengthening
|
||
As of 23 June 2026
